Molecular characterization of CD8 Tem cells and their TCR clonotypes during flare events establishes a critical step toward expanding our understanding of immune repertoire monitoring, and may also provide a foundation for the development of the next generation of therapeutic interventions in the management of SLE. The gene discussed is CD8A; the disease is systemic lupus erythematosus.